Niva Bupa Reports Strong H1'FY2026 Results with 22.9% GWP Growth and New Product Launch
Niva Bupa reported strong H1'FY2026 results with GWP growing 22.9% to ₹3,983 crore and PAT at ₹132 crore. The company launched 'ReAssure 3.0' and improved its Combined Insurance Service Ratio.
The strong financial performance, strategic product launch, and positive operational metrics suggest a high positive impact on the company's market position and future growth prospects.
The company reported significant growth in Gross Written Premium and Profit After Tax, alongside an improved Combined Insurance Service Ratio and a new product launch, indicating strong financial and operational performance.
Niva Bupa Health Insurance Company Limited presented its Investor Presentation for the unaudited financial results for the quarter and half year ended September 30, 2025. * The company achieved a Gross Written Premium (GWP) growth of 22.9% year-on-year, reaching ₹3,983 crore (without 1/n) and ₹3,475 crore (with 1/n) at a 7.2% growth in H1'FY2026. * IFRS Profit After Tax (PAT) for H1'FY2026 was ₹132 crore, a significant increase from ₹60 crore in H1'FY2025. * The Combined Insurance Service Ratio (CISR) improved to 103.1% in H1'FY2026 from 104.2% in H1'FY2025. * Niva Bupa's Retail Health market share stood at 9.9% in H1'FY2026. * The MD & CEO commented on the sustained growth of the Indian economy and the elimination of GST on Retail Health, PA & Travel insurance, which makes health insurance more affordable. The health segment grew by 9.5% in H1'FY2026. * The company launched 'ReAssure 3.0', India’s first truly unlimited health insurance plan, featuring several innovative and customer-centric options. * Customer service showed improvement with a Weighted Episodal NPS of 57 for H1'FY2026, a 2-point increase over FY2025. * Niva Bupa won two awards at the Pitch BFSI Marketing Awards 2025 for Most Effective 360 Degree Marketing Campaign and Most Effective Use of Traditional Marketing.
What to do with a filing like this
Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.